Clinical trial
Characteristics of Treatment Responders to Galantamine
NCT01029132
Study timeline
Study start (unknown)2007-04-01Date precision: month
Registry last updated2016-01-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Dementiaunresolved
Interventions
galantamineDRUG · verified · RxNorm: galantamine
Sponsors & collaborators
Samsung Medical Centerlead sponsor
Janssen Korea, Ltd., Koreacollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01029132 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.